Momelotinib + Rosuvastatin Interaction
Unknowninteraction on record
Description
( 7.1 ) • Breast Cancer Resistance Protein (BCRP) substrates: Reduce rosuvastatin (BCRP substrate) dosage. When administered concomitantly with OJJAARA, initiate rosuvastatin (BCRP substrate) at 5 mg and do not increase to more than 10 mg once daily.
Source: FDA drug label - momelotinib